BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37984828)

  • 21. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P; Churee C; Pattamadilok B
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study on the use of fractional CO
    Bakr RM; Abdel-Gaber RM; Tawfik YM
    Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of Vitiligo (A randomized clinical trial).
    Afify AA; Zuelfakkar NM; Eshafi MA
    Lasers Med Sci; 2021 Sep; 36(7):1479-1486. PubMed ID: 33236202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
    Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
    Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effect of combined intralesional injection of prostaglandin F2α with narrow band UVB phototherapy in treatment of resistant cases of vitiligo.
    Eldelee SA; Gheida SF; Sarhan NI; Ibrahim ZA; Elfar NN
    J Dermatolog Treat; 2021 Jun; 32(4):383-390. PubMed ID: 31437059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of vitiligo to narrowband ultraviolet B and oral antioxidants.
    Elgoweini M; Nour El Din N
    J Clin Pharmacol; 2009 Jul; 49(7):852-5. PubMed ID: 19553407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study.
    Esmat SM; El-Mofty M; Rasheed H; Mostafa WZ; Anbar TS; Abdallah M; Bassiouny D; Abdel-Halim D; Hegazy R; Eid AA; Nassar A; Abdel-Aziz RT; Fawzy MM; Gawdat HI; El Hawary M; Sany I; Shalaby S; Ragab N; Abdel-Gaber RM; Tawfik YM; El-Bassiouny M; El-Husseiny R; Attia MS; Farid C; Genedy RM; Mogawer RM
    Photodermatol Photoimmunol Photomed; 2022 May; 38(3):277-287. PubMed ID: 34726808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
    Sonthalia S
    J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient reported outcomes for intensified versus conventional NB-UVB treatment in non-segmental vitiligo.
    Uitentuis SE; Narayan VS; Wind BS; Bekkenk MW; de Rie MA; Wolkerstorfer A
    J Dermatolog Treat; 2019 Sep; 30(6):594-597. PubMed ID: 30497304
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
    Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
    Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.
    Kim WI; Kim S; Lee SH; Cho MK
    Lasers Med Sci; 2021 Feb; 36(1):165-173. PubMed ID: 32572662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of stable nonsegmental vitiligo using transdermal delivery of 5-fluorouracil by fractional CO
    Elgarhy LH; El-Tatawy RA; Ali DM; Anber DM; Iskandarani YA; Ismail MA
    J Cosmet Dermatol; 2022 Sep; 21(9):3832-3841. PubMed ID: 35005831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.